Han Shen

4PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 26, 2025
miR-143-3p Promotes TSCM Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1.

Wenkai Shi, Jieming Hu, Hongqiong Wang

|May 27, 2024
Immune checkpoint inhibitors: breakthroughs in cancer treatment.

Xueqing Kong, Jinyi Zhang, Shuwei Chen

|Sep 09, 2023
Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning.

Biaojie Huang, Qiurui Chen, Zhiyun Ye

|Jul 03, 2023
Cancer-associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD-1 inhibitors and antiangiogenic agents in hepatocellular carcinoma.

Qiurui Chen, Xuejia Wang, Yichen Zheng

Pageof 1

Frequent Collaborators

2 joint publications

Qiurui Chen

2 joint publications

Rongxin Zhang